The Role of NPR-C In Modulation Of Acute Lung Injury

NPR-C 在调节急性肺损伤中的作用

基本信息

  • 批准号:
    9235305
  • 负责人:
  • 金额:
    $ 30.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2019-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This proposal aims to determine the role of natriuretic peptide receptor-C (NPR-C) in mitigating acute lung injury. Diseases such as pneumonia, congestive heart failure, and acute respiratory distress syndrome (ARDS) are characterized by movement of fluid, protein and cells from the pulmonary circulation to the interstitial and alveola space. This transudation of vascular fluid impairs gas exchange and initiates a cascade of inflammatory events that leads to acute lung failure. Cell signaling pathways that regulate fluid and cellular transudation across the pulmonary vascular membrane play critical roles in determining the extent of lung damage that occurs and the time it takes for the lung to recover. The natriuretic peptides (NP) are a family of proteins that play critically important roles in maintaining appropriate amounts of fluid in the circulation. NPs are released from the heart in response to increased blood volume and act to increase the permeability of blood vessels, thereby facilitating transudation of fluid, solutes and proteins from the intravascular to the interstitial space of systemic vascular beds. In the pulmonary circulation, however, NPs appear to protect against increased acute lung injury and pulmonary edema formation. In fact, numerous studies have shown that atrial natriuretic peptide (ANP) blunts acute lung injury in animal models and clinical studies. This differential effect of NPs on vascular permeability in the systemic and pulmonary vascular beds may be explained by differences in effects of the NP-receptors. Previous studies by other investigators suggest that enhancement of vascular permeability is mediated by NPR-A. However, recent studies from our laboratory suggest that the protective effects of NPs on acute lung injury are mediated by NPR-C. This proposal will test the hypothesis that NPR-C protects against acute lung injury by determining if lung injury is worse in mice lacking NPR-C and if NPs fail to protect against lung injury in NPR-C deficient mice. The proposal will also determine if barrier function in pulmonary vascular endothelial cells can be altered by increasing or decreasing NPR-C expression. Other studies aim to elucidate downstream signaling pathways responsible for the protective effects of NPR-C by determining if the protective effect of NPR-C is mediated by activation of G-inhibitory protein (Gai) and downstream modulation of cAMP. Finally, animal studies will be performed to determine if increased expression of NPR-C in vivo can protect against acute lung injury. Pulmonary edema formation is the primary cause of morbidity and mortality in severe cases of acute respiratory failure. Identification of receptors and their associated signal transduction pathways responsible for maintenance of intact pulmonary endothelial barrier function is vital to furthering our understanding of pulmonary permeability and developing new therapies for patients with acute lung injury.
 描述(由申请人提供):本提案旨在确定利尿钠肽受体-C (NPR-C) 在减轻急性肺损伤中的作用。肺炎、充血性心力衰竭和急性呼吸窘迫综合征 (ARDS) 等疾病的特征是液体、蛋白质和细胞从肺循环移动到间质和肺泡空间。血管液体的渗出会损害气体交换并引发一系列炎症事件,导致急性肺衰竭。调节穿过肺血管膜的液体和细胞渗出的细胞信号传导通路在确定肺损伤发生的程度以及肺恢复所需的时间方面发挥着关键作用。利钠肽 (NP) 是一个蛋白质家族,在维持循环中适量的液体方面发挥着至关重要的作用。心脏响应血容量增加而释放纳米颗粒,并起到增加血管通透性的作用,从而促进液体、溶质和蛋白质从血管内渗出到全身血管床的间隙空间。然而,在肺循环中,纳米粒子似乎可以防止急性肺损伤和肺水肿形成的增加。事实上,大量研究表明,在动物模型和临床研究中,心房钠尿肽 (ANP) 可以减轻急性肺损伤。纳米颗粒对血管通透性的不同影响 全身血管床和肺血管床的差异可以通过 NP 受体的作用差异来解释。其他研究者之前的研究表明,血管通透性的增强是由 NPR-A 介导的。然而,我们实验室最近的研究表明,NPs 对急性肺损伤的保护作用是由 NPR-C 介导的。该提案将通过确定缺乏 NPR-C 的小鼠的肺损伤是否更严重以及 NP 是否无法防止 NPR-C 缺陷小鼠的肺损伤来测试 NPR-C 可以预防急性肺损伤的假设。该提案还将确定是否可以通过增加或减少 NPR-C 表达来改变肺血管内皮细胞的屏障功能。其他研究旨在通过确定 NPR-C 的保护作用是否由 G 抑制蛋白 (Gai) 的激活和 cAMP 的下游调节介导来阐明负责 NPR-C 保护作用的下游信号通路。最后,将进行动物研究以确定体内 NPR-C 表达的增加是否可以预防急性肺损伤。肺水肿形成是严重急性呼吸衰竭病例发病和死亡的主要原因。识别负责维持完整肺内皮屏障功能的受体及其相关信号转导途径对于进一步了解肺通透性并为急性肺损伤患者开发新疗法至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elizabeth O Harrington其他文献

Elizabeth O Harrington的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elizabeth O Harrington', 18)}}的其他基金

“Phenotyping Heart Failure with Preserved Ejection Fraction Using Non- Invasive Biomarkers
使用非侵入性生物标志物通过保留射血分数对心力衰竭进行表型分析
  • 批准号:
    10624557
  • 财政年份:
    2022
  • 资助金额:
    $ 30.25万
  • 项目类别:
Uncoupling of IL-1 beta and VEGF-A Crosstalk Contributes to Impaired Arteriogenesis Response to Ischemia in Chronic Diabetes Mellitus
IL-1β 和 VEGF-A 串扰的解偶联导致慢性糖尿病缺血的动脉生成反应受损
  • 批准号:
    10549633
  • 财政年份:
    2021
  • 资助金额:
    $ 30.25万
  • 项目类别:
Brown Respiratory Research Training Program
布朗呼吸研究培训计划
  • 批准号:
    10270460
  • 财政年份:
    2017
  • 资助金额:
    $ 30.25万
  • 项目类别:
Brown Respiratory Research Training Program
布朗呼吸研究培训计划
  • 批准号:
    10581473
  • 财政年份:
    2017
  • 资助金额:
    $ 30.25万
  • 项目类别:
Cell Isolation and Organ Function Core
细胞分离和器官功能核心
  • 批准号:
    10200077
  • 财政年份:
    2013
  • 资助金额:
    $ 30.25万
  • 项目类别:
Uncoupling of IL-1 beta and VEGF-A Crosstalk Contributes to Impaired Arteriogenesis Response to Ischemia in Chronic Diabetes Mellitus
IL-1β 和 VEGF-A 串扰的解偶联导致慢性糖尿病缺血的动脉生成反应受损
  • 批准号:
    10579818
  • 财政年份:
    2013
  • 资助金额:
    $ 30.25万
  • 项目类别:
Cell Isolation and Organ Function Core
细胞分离和器官功能核心
  • 批准号:
    10437830
  • 财政年份:
    2013
  • 资助金额:
    $ 30.25万
  • 项目类别:
Alpert Medical School Summer Research Program
阿尔珀特医学院暑期研究计划
  • 批准号:
    10117082
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:
Alpert Medical School Summer Research Program
阿尔珀特医学院暑期研究计划
  • 批准号:
    8794651
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:
Alpert Medical School Summer Research Program
阿尔珀特医学院暑期研究计划
  • 批准号:
    9180718
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:

相似海外基金

Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
  • 批准号:
    10591804
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
  • 批准号:
    10741574
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
  • 批准号:
    10720687
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
  • 批准号:
    10719249
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
  • 批准号:
    23K07651
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
  • 批准号:
    10679944
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
  • 批准号:
    10575258
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
  • 批准号:
    10701207
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
  • 批准号:
    MR/Y000404/1
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了